Bei Akademie registrieren
Lonza Group, CH0013841017

Lonza Group stock pre-market at EUR 648.80: CDMO before the Xetra open

Published on 10/19/2026 at 08:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The Swiss CDMO serves healthcare customers from development through manufacturing. At Lang & Schwarz the stock trades pre-market at EUR 648.80 on October 19, 2026.

Trading context for Monday

  • Lonza serves healthcare customers through contract development and manufacturing services.
  • The company’s home market is the Swiss Market Index in Switzerland.
  • Lonza Group stock trades pre-market at EUR 648.80 at 8:00 a.m. CEST at Lang & Schwarz on October 19, 2026.
Makroaufnahme von Bioreaktor-Glasrohren mit bernsteinfarbiger Flüssigkeit und aufsteigenden Blasen
Lonza CH0013841017 Makro Bioreaktor Glasrohre mit bernsteinfarbiger Fluessigkeit und feinen Blasen darin, Illustration mit AI erstellt.

Lonza develops and manufactures medicines for healthcare customers as a contract development and manufacturing organization, spanning early development through drug-substance and drug-product manufacturing, according to Lonza. Lonza Group stock trades pre-market at EUR 648.80 at 8:00 a.m. CEST at Lang & Schwarz on October 19, 2026.

Ahead of the Xetra open

The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Lonza Group stock.

Lonza and its market

Lonza shares are listed on the SIX Swiss Exchange and are included in the Swiss Market Index, according to the company’s company overview.

Market context: Market report SMI.

More news and analysis on Lonza Group stock

Disclaimer...
en | CH0013841017 | LONZA GROUP | boerse | 70357981 | bgmi